The Cytel Blog: Perspectives on Enquiry & Evidence

The world's leading supplier of statistical insight to decision-makers in the lifesciences brings you debate and discussion of the newest trends in statistics and quantitative strategy.

September 15, 2021

A Bayesian Optimal Design Advancing the Precision Medicine Approach

There is recognized heterogeneity within any given tumor‐type from patient to patient (inter‐patient heterogeneity),..

Read article

July 2, 2021

Use of Rolling-enrollment Designs to Accelerate Clinical Trials

Popular statistical designs, such as CRM (O’Quigley et al., 1990), mTPI-2 (Guo et al., 2017), and i3+3 (Liu et al.,..

Read article

June 24, 2021

Myths surrounding the use of synthetic control arms in clinical trials: Part 3

Synthetic control arms (SCAs) leverage real world data from various sources or evaluations of historical clinical data..

Read article

December 18, 2019

Year-End Roundup: Your Favorite Blog Posts of 2019

With only two weeks left for this fabulous year to end, we would like to thank all our blog subscribers and new readers..

Read article

November 5, 2019

Interview with Kannan Natarajan: Drug Development in Rare Diseases - Need for Innovation in Statistical Thinking

Cytel is delighted to have Kannan Natarajan speaking at the “Complex Innovative Trial Design Symposium and East User..

Read article

|All posts|

The Cytel Blog: Perspectives on Enquiry & Evidence

A Bayesian Optimal Design Advancing the Precision Medicine Approach

Use of Rolling-enrollment Designs to Accelerate Clinical Trials

Myths surrounding the use of synthetic control arms in clinical trials: Part 3

Year-End Roundup: Your Favorite Blog Posts of 2019

Interview with Kannan Natarajan: Drug Development in Rare Diseases - Need for Innovation in Statistical Thinking

Subscribe to our weekly newsletter